Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Investing

Sale process begins for Savile Row tailor brand Gieves and Hawkes

by
July 14, 2022
in Investing
0
Sale process begins for Savile Row tailor brand Gieves and Hawkes
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

British luxury menswear retailer Gieves and Hawkes is up for sale, with liquidators keen to attract prospective buyers for the 250-year-old Savile Row brand.

Advisers started formally soliciting bids this week, according to Bloomberg.

This follows its parent company, Hong Kong-listed fashion group Trinity, falling into liquidation last year.

It has reported that the sale will include Gieves and Hawkes’ business in the UK, alongside its operations and licensing agreements in Greater China.

Trinity’s liquidators aim to find a buyer for Gieves and Hawkes in the third quarter.

Gieves and Hawkes, headquartered at No. 1 Savile Row in London, had 58 stores in 25 cities as of May last year.

Its roots are in the military tailoring tradition, and the brand holds three royal warrants.

The tailor has counted every British monarch since George III among its customers, along with former Prime Minister Sir Winston Churchill.

Some of its present-day high-profile clients include Prince William and David Beckham.

Read more:
Sale process begins for Savile Row tailor brand Gieves and Hawkes

Previous Post

Rail workers to strike across Britain on 27 July

Next Post

Born out of jealousy: 1 in 5 businesses started because entrepreneurs were jealous of their boss

Next Post
Born out of jealousy: 1 in 5 businesses started because entrepreneurs were jealous of their boss

Born out of jealousy: 1 in 5 businesses started because entrepreneurs were jealous of their boss

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021
Pints of champagne could be the next ‘Brexit dividend’

Pints of champagne could be the next ‘Brexit dividend’

December 24, 2021

How Double Standards Erode Free Speech

0

0

0

0

How Double Standards Erode Free Speech

October 11, 2025

Breaking Free From State Rule

October 11, 2025
PPE Medpro consortium signals willingness to settle as spotlight turns to government’s £85m missed resale opportunity

PPE Medpro consortium signals willingness to settle as spotlight turns to government’s £85m missed resale opportunity

October 11, 2025

Leading pharmacist warns of patient safety risk due to UK medicine pack barcode errors, as petition urges MHRA to take action.

October 11, 2025

Recent News

How Double Standards Erode Free Speech

October 11, 2025

Breaking Free From State Rule

October 11, 2025
PPE Medpro consortium signals willingness to settle as spotlight turns to government’s £85m missed resale opportunity

PPE Medpro consortium signals willingness to settle as spotlight turns to government’s £85m missed resale opportunity

October 11, 2025

Leading pharmacist warns of patient safety risk due to UK medicine pack barcode errors, as petition urges MHRA to take action.

October 11, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.